Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator announces second round of awards

(Alzheimer's Drug Discovery Foundation) The Alzheimer's Drug Discovery Foundation (ADDF) announced 6 new investments totaling $6 million through its Diagnostics Accelerator initiative. These current awards include research for blood tests in various stages of development, with one close to becoming a viable diagnostic tool for early detection of Alzheimer's disease. Other research efforts include the development of ocular and genetic tests that will aid in diagnosis and appropriate clinical tria...